Cargando…
Preliminary Exploration of a New Therapy for Interstitial Cystitis/Bladder Pain Syndrome: Botulinum Toxin A Combined with Sapylin
Interstitial cystitis/bladder pain syndrome (IC/BPS) is an intractable disease without long-term effective therapy. This study aims to evaluate the efficacy and safety of botulinum toxin A (BoNT/A) plus Sapylin, which might modulate the immune response of the bladder in the treatment of IC/BPS patie...
Autores principales: | Li, Wenshuang, Zheng, Zhenming, Ma, Kaiqun, Zhang, Caixia, Li, Kuiqing, Tayier, Paierhati, Yao, Yousheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783506/ https://www.ncbi.nlm.nih.gov/pubmed/36548729 http://dx.doi.org/10.3390/toxins14120832 |
Ejemplares similares
-
Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients
por: Zheng, Zhenming, et al.
Publicado: (2023) -
The study on the function and cell source of interleukin‐6 in interstitial cystitis/bladder painful syndrome rat model
por: Zheng, Zhenming, et al.
Publicado: (2021) -
Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis
por: Chiu, Bin, et al.
Publicado: (2016) -
Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer
por: Zheng, Zhenming, et al.
Publicado: (2021) -
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)